The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Pharmaceutical Contract Manufacturing & Contract-Global Market Insights and Sales Trends 2024

Pharmaceutical Contract Manufacturing & Contract-Global Market Insights and Sales Trends 2024

Publishing Date : Nov, 2023

License Type :
 

Report Code : 1828125

No of Pages : 110

Ask Your Query

Synopsis

Contract pharmaceutical manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.

The global Pharmaceutical Contract Manufacturing & Contract market size is expected to reach US$ 136820 million by 2029, growing at a CAGR of 6.4% from 2023 to 2029. The market is mainly driven by the significant applications of Pharmaceutical Contract Manufacturing & Contract in various end use industries.

The expanding demands from the Small Medium Enterprise and Large Enterprise, are propelling Pharmaceutical Contract Manufacturing & Contract market. Manufacturing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Research segment is estimated at % CAGR for the next seven-year period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs.

However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pharmaceutical Contract Manufacturing & Contract, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Pharmaceutical Contract Manufacturing & Contract market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Pharmaceutical Contract Manufacturing & Contract market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pharmaceutical Contract Manufacturing & Contract sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Pharmaceutical Contract Manufacturing & Contract covered in this report include Catalent, Pharmaceutical Product Development LLC, AbbVie, Baxter BioPharma Solutions, Patheon, Grifols International, Dalton Pharma Services, Boehringer Ingelheim Biopharmaceuticals GmBh and Lonza AG., etc.

The global Pharmaceutical Contract Manufacturing & Contract market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • Catalent
  • Pharmaceutical Product Development LLC
  • AbbVie
  • Baxter BioPharma Solutions
  • Patheon
  • Grifols International
  • Dalton Pharma Services
  • Boehringer Ingelheim Biopharmaceuticals GmBh
  • Lonza AG.
  • Grifols S.A
  • Jubilant Life Sciences Limited
  • QuintilesIMS
  • Vetter Pharma
  • Ligand Pharmaceuticals, Inc.
  • Bausch Health
  • Recipharm AB
  • Famar Health Care Services
  • West Pharmaceutical Services, Inc.

Global Pharmaceutical Contract Manufacturing & Contract market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Pharmaceutical Contract Manufacturing & Contract market, Segment by Type:

  • Manufacturing
  • Research

Global Pharmaceutical Contract Manufacturing & Contract market, by Application

  • Small Medium Enterprise
  • Large Enterprise

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Pharmaceutical Contract Manufacturing & Contract companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

Index

1 Market Overview of Pharmaceutical Contract Manufacturing & Contract
1.1 Pharmaceutical Contract Manufacturing & Contract Market Overview
1.1.1 Pharmaceutical Contract Manufacturing & Contract Product Scope
1.1.2 Pharmaceutical Contract Manufacturing & Contract Market Status and Outlook
1.2 Global Pharmaceutical Contract Manufacturing & Contract Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Pharmaceutical Contract Manufacturing & Contract Market Size by Region (2018-2029)
1.4 Global Pharmaceutical Contract Manufacturing & Contract Historic Market Size by Region (2018-2023)
1.5 Global Pharmaceutical Contract Manufacturing & Contract Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Pharmaceutical Contract Manufacturing & Contract Market Size (2018-2029)
1.6.1 North America Pharmaceutical Contract Manufacturing & Contract Market Size (2018-2029)
1.6.2 Europe Pharmaceutical Contract Manufacturing & Contract Market Size (2018-2029)
1.6.3 Asia-Pacific Pharmaceutical Contract Manufacturing & Contract Market Size (2018-2029)
1.6.4 Latin America Pharmaceutical Contract Manufacturing & Contract Market Size (2018-2029)
1.6.5 Middle East & Africa Pharmaceutical Contract Manufacturing & Contract Market Size (2018-2029)
2 Pharmaceutical Contract Manufacturing & Contract Market by Type
2.1 Introduction
2.1.1 Manufacturing
2.1.2 Research
2.2 Global Pharmaceutical Contract Manufacturing & Contract Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Pharmaceutical Contract Manufacturing & Contract Historic Market Size by Type (2018-2023)
2.2.2 Global Pharmaceutical Contract Manufacturing & Contract Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Pharmaceutical Contract Manufacturing & Contract Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Pharmaceutical Contract Manufacturing & Contract Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Pharmaceutical Contract Manufacturing & Contract Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Pharmaceutical Contract Manufacturing & Contract Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Pharmaceutical Contract Manufacturing & Contract Revenue Breakdown by Type (2018-2029)
3 Pharmaceutical Contract Manufacturing & Contract Market Overview by Application
3.1 Introduction
3.1.1 Small Medium Enterprise
3.1.2 Large Enterprise
3.2 Global Pharmaceutical Contract Manufacturing & Contract Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Pharmaceutical Contract Manufacturing & Contract Historic Market Size by Application (2018-2023)
3.2.2 Global Pharmaceutical Contract Manufacturing & Contract Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Pharmaceutical Contract Manufacturing & Contract Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Pharmaceutical Contract Manufacturing & Contract Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Pharmaceutical Contract Manufacturing & Contract Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Pharmaceutical Contract Manufacturing & Contract Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Pharmaceutical Contract Manufacturing & Contract Revenue Breakdown by Application (2018-2029)
4 Pharmaceutical Contract Manufacturing & Contract Competition Analysis by Players
4.1 Global Pharmaceutical Contract Manufacturing & Contract Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pharmaceutical Contract Manufacturing & Contract as of 2022)
4.3 Date of Key Players Enter into Pharmaceutical Contract Manufacturing & Contract Market
4.4 Global Top Players Pharmaceutical Contract Manufacturing & Contract Headquarters and Area Served
4.5 Key Players Pharmaceutical Contract Manufacturing & Contract Product Solution and Service
4.6 Competitive Status
4.6.1 Pharmaceutical Contract Manufacturing & Contract Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Catalent
5.1.1 Catalent Profile
5.1.2 Catalent Main Business
5.1.3 Catalent Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
5.1.4 Catalent Pharmaceutical Contract Manufacturing & Contract Revenue (US$ Million) & (2018-2023)
5.1.5 Catalent Recent Developments
5.2 Pharmaceutical Product Development LLC
5.2.1 Pharmaceutical Product Development LLC Profile
5.2.2 Pharmaceutical Product Development LLC Main Business
5.2.3 Pharmaceutical Product Development LLC Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
5.2.4 Pharmaceutical Product Development LLC Pharmaceutical Contract Manufacturing & Contract Revenue (US$ Million) & (2018-2023)
5.2.5 Pharmaceutical Product Development LLC Recent Developments
5.3 AbbVie
5.3.1 AbbVie Profile
5.3.2 AbbVie Main Business
5.3.3 AbbVie Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
5.3.4 AbbVie Pharmaceutical Contract Manufacturing & Contract Revenue (US$ Million) & (2018-2023)
5.3.5 Baxter BioPharma Solutions Recent Developments
5.4 Baxter BioPharma Solutions
5.4.1 Baxter BioPharma Solutions Profile
5.4.2 Baxter BioPharma Solutions Main Business
5.4.3 Baxter BioPharma Solutions Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
5.4.4 Baxter BioPharma Solutions Pharmaceutical Contract Manufacturing & Contract Revenue (US$ Million) & (2018-2023)
5.4.5 Baxter BioPharma Solutions Recent Developments
5.5 Patheon
5.5.1 Patheon Profile
5.5.2 Patheon Main Business
5.5.3 Patheon Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
5.5.4 Patheon Pharmaceutical Contract Manufacturing & Contract Revenue (US$ Million) & (2018-2023)
5.5.5 Patheon Recent Developments
5.6 Grifols International
5.6.1 Grifols International Profile
5.6.2 Grifols International Main Business
5.6.3 Grifols International Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
5.6.4 Grifols International Pharmaceutical Contract Manufacturing & Contract Revenue (US$ Million) & (2018-2023)
5.6.5 Grifols International Recent Developments
5.7 Dalton Pharma Services
5.7.1 Dalton Pharma Services Profile
5.7.2 Dalton Pharma Services Main Business
5.7.3 Dalton Pharma Services Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
5.7.4 Dalton Pharma Services Pharmaceutical Contract Manufacturing & Contract Revenue (US$ Million) & (2018-2023)
5.7.5 Dalton Pharma Services Recent Developments
5.8 Boehringer Ingelheim Biopharmaceuticals GmBh
5.8.1 Boehringer Ingelheim Biopharmaceuticals GmBh Profile
5.8.2 Boehringer Ingelheim Biopharmaceuticals GmBh Main Business
5.8.3 Boehringer Ingelheim Biopharmaceuticals GmBh Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
5.8.4 Boehringer Ingelheim Biopharmaceuticals GmBh Pharmaceutical Contract Manufacturing & Contract Revenue (US$ Million) & (2018-2023)
5.8.5 Boehringer Ingelheim Biopharmaceuticals GmBh Recent Developments
5.9 Lonza AG.
5.9.1 Lonza AG. Profile
5.9.2 Lonza AG. Main Business
5.9.3 Lonza AG. Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
5.9.4 Lonza AG. Pharmaceutical Contract Manufacturing & Contract Revenue (US$ Million) & (2018-2023)
5.9.5 Lonza AG. Recent Developments
5.10 Grifols S.A
5.10.1 Grifols S.A Profile
5.10.2 Grifols S.A Main Business
5.10.3 Grifols S.A Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
5.10.4 Grifols S.A Pharmaceutical Contract Manufacturing & Contract Revenue (US$ Million) & (2018-2023)
5.10.5 Grifols S.A Recent Developments
5.11 Jubilant Life Sciences Limited
5.11.1 Jubilant Life Sciences Limited Profile
5.11.2 Jubilant Life Sciences Limited Main Business
5.11.3 Jubilant Life Sciences Limited Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
5.11.4 Jubilant Life Sciences Limited Pharmaceutical Contract Manufacturing & Contract Revenue (US$ Million) & (2018-2023)
5.11.5 Jubilant Life Sciences Limited Recent Developments
5.12 QuintilesIMS
5.12.1 QuintilesIMS Profile
5.12.2 QuintilesIMS Main Business
5.12.3 QuintilesIMS Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
5.12.4 QuintilesIMS Pharmaceutical Contract Manufacturing & Contract Revenue (US$ Million) & (2018-2023)
5.12.5 QuintilesIMS Recent Developments
5.13 Vetter Pharma
5.13.1 Vetter Pharma Profile
5.13.2 Vetter Pharma Main Business
5.13.3 Vetter Pharma Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
5.13.4 Vetter Pharma Pharmaceutical Contract Manufacturing & Contract Revenue (US$ Million) & (2018-2023)
5.13.5 Vetter Pharma Recent Developments
5.14 Ligand Pharmaceuticals, Inc.
5.14.1 Ligand Pharmaceuticals, Inc. Profile
5.14.2 Ligand Pharmaceuticals, Inc. Main Business
5.14.3 Ligand Pharmaceuticals, Inc. Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
5.14.4 Ligand Pharmaceuticals, Inc. Pharmaceutical Contract Manufacturing & Contract Revenue (US$ Million) & (2018-2023)
5.14.5 Ligand Pharmaceuticals, Inc. Recent Developments
5.15 Bausch Health
5.15.1 Bausch Health Profile
5.15.2 Bausch Health Main Business
5.15.3 Bausch Health Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
5.15.4 Bausch Health Pharmaceutical Contract Manufacturing & Contract Revenue (US$ Million) & (2018-2023)
5.15.5 Bausch Health Recent Developments
5.16 Recipharm AB
5.16.1 Recipharm AB Profile
5.16.2 Recipharm AB Main Business
5.16.3 Recipharm AB Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
5.16.4 Recipharm AB Pharmaceutical Contract Manufacturing & Contract Revenue (US$ Million) & (2018-2023)
5.16.5 Recipharm AB Recent Developments
5.17 Famar Health Care Services
5.17.1 Famar Health Care Services Profile
5.17.2 Famar Health Care Services Main Business
5.17.3 Famar Health Care Services Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
5.17.4 Famar Health Care Services Pharmaceutical Contract Manufacturing & Contract Revenue (US$ Million) & (2018-2023)
5.17.5 Famar Health Care Services Recent Developments
5.18 West Pharmaceutical Services, Inc.
5.18.1 West Pharmaceutical Services, Inc. Profile
5.18.2 West Pharmaceutical Services, Inc. Main Business
5.18.3 West Pharmaceutical Services, Inc. Pharmaceutical Contract Manufacturing & Contract Products, Services and Solutions
5.18.4 West Pharmaceutical Services, Inc. Pharmaceutical Contract Manufacturing & Contract Revenue (US$ Million) & (2018-2023)
5.18.5 West Pharmaceutical Services, Inc. Recent Developments
6 North America
6.1 North America Pharmaceutical Contract Manufacturing & Contract Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Pharmaceutical Contract Manufacturing & Contract Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Contract Manufacturing & Contract Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Pharmaceutical Contract Manufacturing & Contract Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Contract Manufacturing & Contract Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Pharmaceutical Contract Manufacturing & Contract Market Dynamics
11.1 Pharmaceutical Contract Manufacturing & Contract Industry Trends
11.2 Pharmaceutical Contract Manufacturing & Contract Market Drivers
11.3 Pharmaceutical Contract Manufacturing & Contract Market Challenges
11.4 Pharmaceutical Contract Manufacturing & Contract Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock